These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1326384)

  • 1. [Circadian changes of atrial natriuretic peptide, cyclic AMP, cyclic GMP, sodium, blood pressure and heart rate in normal subjects].
    Xu CT; Wang YM
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jul; 50(1):37-40. PubMed ID: 1326384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma atrial natriuretic peptide and cyclic nucleotide levels before and after a marathon.
    Lijnen P; Hespel P; M'Buyamba-Kabangu JR; Goris M; Lysens R; Vanden Eynde E; Fagard R; Amery A
    J Appl Physiol (1985); 1987 Sep; 63(3):1180-4. PubMed ID: 2820919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide, renin activity, aldosterone, urine volume and electrolytes during a 24-h sleep-wake cycle in man.
    Leppäluoto J; Ruskoaho H
    Acta Physiol Scand; 1990 May; 139(1):47-53. PubMed ID: 2141447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Values of atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in cardioversion].
    Lechleitner P; Genser N; Hauptlorenz S; Putensen C; Mitterschiffthaler G; Artner-Dworzak E; Puschendorf B; Dienstl F
    Z Kardiol; 1991 Sep; 80(9):574-9. PubMed ID: 1661054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of diurnal rhythm, posture and right atrial size on plasma atrial natriuretic peptide levels.
    Weil J; Strom TM; Heim JM; Lang RE; Schindler M; Haufe M; Vogel M; Gerzer R
    Z Kardiol; 1988; 77 Suppl 2():36-40. PubMed ID: 2841814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diurnal and postural variations in plasma atrial natriuretic factor, plasma guanosine 3':5'-cyclic monophosphate and sodium excretion.
    Bell GM; Atlas SA; Pecker M; Sealey JE; James G; Laragh JH
    Clin Sci (Lond); 1990 Oct; 79(4):371-6. PubMed ID: 2171858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial natriuretic peptide, sodium retention, and proteinuria in nephrotic syndrome.
    Plum J; Mirzaian Y; Grabensee B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1034-42. PubMed ID: 8671965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologic role of endogenous human atrial natriuretic peptide in preeclamptic pregnancies.
    Miyamoto S; Shimokawa H; Sumioki H; Nakano H
    Am J Obstet Gynecol; 1989 Jan; 160(1):155-9. PubMed ID: 2536220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man.
    Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased plasma cyclic guanosine monophosphate concentrations in children with high levels of circulating atrial natriuretic peptide.
    Weil J; Gerzer R; Strom T; Lang RE; Döhlemann C; Knorr D; Bidlingmaier F
    Pediatrics; 1987 Oct; 80(4):545-8. PubMed ID: 2821478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circadian rhythms of atrial natriuretic peptide, blood pressure and heart rate in normal subjects.
    Portaluppi F; Montanari L; Bagni B; degli Uberti E; Trasforini G; Margutti A
    Cardiology; 1989; 76(6):428-32. PubMed ID: 2532955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure.
    Moe GW; Canepa-Anson R; Armstrong PW
    J Cardiovasc Pharmacol; 1992 May; 19(5):691-700. PubMed ID: 1381766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alteration of atrial natriuretic peptide and cyclic GMP in cerebrospinal fluid in canine kaolin-induced hydrocephalus].
    Fukushima T
    No To Shinkei; 1992 May; 44(5):457-62. PubMed ID: 1325821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
    J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of dihydroxyacetophenone on pulmonary hemodynamics and plasma ANP as well as cAMP/cGMP level in patients with chronic obstructive pulmonary disease].
    Lin CL; Zhang ZX; Xu YJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Mar; 15(3):131-3. PubMed ID: 7647523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between atrial natriuretic polypeptide and cyclic 3'5'-guanosine monophosphate in human plasma.
    Fujio N; Ohashi M; Nawata H; Kato K; Ibayashi H; Matsuo H
    J Lab Clin Med; 1987 Jun; 109(6):706-10. PubMed ID: 3035037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic peptide and cyclic guanosine monophosphate plasma concentrations in patients with thyrotoxicosis and atrial fibrillation. Effect of short-term methimazole therapy.
    Czekalski S; Widecka K; Gozdzik J; Ciechanowski K; Krzyzanowska-Swiniarska B; Gromniak E; Gruszczynska M
    J Endocrinol Invest; 1994 May; 17(5):341-6. PubMed ID: 8077618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
    Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
    J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.